Every story in this section, newest first — page 267 of 373.
Broadcom (NASDAQ:AVGO) reported record financial results for its fiscal first quarter ended February 1, 2026, solidifying its position as a primary beneficiary of the generative artificial intelligence boom.
Performance Shipping (NASDAQ:PSHG), a global specialist in tanker vessel ownership, announced on Wednesday that its full-year net income for 2025 reached $50 million, an increase from the $43.7 million reported in 2024.
Chatham Lodging Trust (NYSE:CLDT), a real estate investment trust (REIT) focused on upscale extended-stay and select-service hotels, announced a major strategic expansion on Wednesday.
TScan Therapeutics (NASDAQ:TCRX), a clinical-stage biopharmaceutical company developing T cell receptor (TCR)-engineered T cell therapies for the treatment of cancer, on Wednesday reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update focused on progress across its allogeneic TCR-T platform.
Real Brokerage (NASDAQ:REAX), a technology platform empowering real estate agents through innovative tools, culture and support, on Wednesday reported financial results for its fourth quarter and full year ended December 31, 2025.
Wallbox (NYSE:WBX) announced fourth-quarter and full-year 2025 financial results on Wednesday, highlighting a disciplined focus on profitability through aggressive cost-cutting and high-margin product expansion.
Advanced Flower Capital (NASDAQ:AFCG) announced its fourth-quarter and full-year 2025 financial results on Wednesday, marking the conclusion of its transformation into a business development company.
Ocugen (NASDAQ:OCGN), a Malvern, Pennsylvania-based clinical-stage biotechnology company developing modifier gene therapies for ophthalmic and other diseases, on Wednesday reported financial results for the fourth quarter and full year ended December 31, 2025, alongside a business update highlighting progress across its three lead modifier gene therapy programs.
Caesarstone (NASDAQ:CSTE), a global pioneer in quartz and porcelain surfaces, reported a fourth-quarter net loss of $87.9 million, or $2.55 per share, as it finalized major components of its multi-year strategic transformation.
Republic Airways Holdings (NASDAQ:RJET) concluded a "transformational" fiscal year 2025 by swinging to a full-year profit of $76.2 million, or $1.87 per share.
Altisource Portfolio Solutions (NASDAQ:ASPS) reported fiscal 2025 results on Wednesday, marking a return to full-year profitability as the company navigates a stabilizing residential real estate market.
Brown-Forman (NYSE:BFA) announced fiscal third-quarter profit of $267 million, or 58 cents per diluted share, comfortably beating the Zacks Consensus Estimate of 48 cents.
Cellectar Biosciences (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company specializing in radioconjugates, reported a significantly reduced net loss for 2025 as it transitioned its lead program, iopofosine I-131, into the final regulatory stages.
Nexxen International (NASDAQ:NEXN), a global ad-tech platform specializing in data and advanced TV, announced record financial results for the fiscal year ended December 31, 2025.
Holley (NYSE:HLLY), the definitive market leader in the high-performance automotive aftermarket, reported a robust finish to fiscal year 2025, swinging to a net profit following a challenging prior year.
Daktronics (NASDAQ:DAKT) posted fiscal third-quarter results that outpaced the prior year across nearly every financial metric, fueled by efficient backlog conversion and stabilized supply chains.
Abercrombie & Fitch (NYSE:ANF) reported record-breaking financial results for fiscal 2025 on Wednesday, as the teen-focused Hollister brand propelled the retailer to its highest annual sales in company history despite a slight cooling at its namesake brand.
EyePoint Pharmaceuticals (NASDAQ:EYPT) entered a critical catalyst year on Wednesday, reporting full-year 2025 results and a clinical roadmap that places its lead candidate, DURAVYU, on track for its first pivotal Phase 3 readout in just months.
Dycom Industries (NYSE:DY) reported blockbuster fiscal 2026 results on Wednesday, as the specialty contractor capitalizes on a massive wave of telecommunications investment and the rapid integration of its latest strategic acquisition.
Bath & Body Works (NYSE:BBWI) reported fourth-quarter 2025 results on Wednesday that exceeded its own conservative projections, though the retailer signaled a cautious road ahead with a 2026 outlook that anticipates continued sales declines.
Miami International Holdings (NYSE:MIAX) reported a significant spike in trading activity for February 2026, as the exchange operator’s aggressive expansion into short-dated options and new trading venues continues to capture a larger slice of the U.S. derivatives market.
Babcock & Wilcox Enterprises (NYSE: BW) reported fourth-quarter and full-year 2025 results on Wednesday, revealing a transformative shift in its business profile as a multi-billion dollar AI data center contract propelled its backlog to record heights.
Stevanato Group (NYSE:STVN) reported a 19% increase in annual earnings on Wednesday, as the Italian drug containment specialist successfully leveraged a record mix of high-value products to offset persistent headwinds in its engineering segment.
European Wax Center (NASDAQ: EWCZ) announced a dip in annual profits and revenue for fiscal 2025 on Wednesday, providing what is likely one of its final public financial updates as the company prepares to go private under a $330 million agreement with General Atlantic.
